Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Morgan

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2013
Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapyRachel E Beard, Daniel Abate-Daga, Shannon F Rosati, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cellsShicheng Yang, Luca Gattinoni, Gattinoni Luca, et al.
Plos One|April 1, 2014
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancerDaniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, et al.
Journal for Immunotherapy of Cancer|January 22, 2020
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor modelsLing Zhang, John S Davies, Carylinda Serna, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2005
High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporationYangbing Zhao, Zhili Zheng, Cyrille J Cohen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptorJames N Kochenderfer, Steven A Feldman, Yangbing Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2002
The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversionJay N Lozier, Amalia Dutra, Evgenia Pak, et al.
Journal of Virology|April 17, 2015
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor ActivityLi Liu, Bhavik Patel, Mustafa H Ghanem, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical applicationLing Zhang, Steven A Feldman, Zhili Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2013
Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapyRachel E Beard, Daniel Abate-Daga, Shannon F Rosati, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cellsShicheng Yang, Luca Gattinoni, Gattinoni Luca, et al.
Plos One|April 1, 2014
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancerDaniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, et al.
Journal for Immunotherapy of Cancer|January 22, 2020
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor modelsLing Zhang, John S Davies, Carylinda Serna, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2005
High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporationYangbing Zhao, Zhili Zheng, Cyrille J Cohen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptorJames N Kochenderfer, Steven A Feldman, Yangbing Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2002
The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversionJay N Lozier, Amalia Dutra, Evgenia Pak, et al.
Journal of Virology|April 17, 2015
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor ActivityLi Liu, Bhavik Patel, Mustafa H Ghanem, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical applicationLing Zhang, Steven A Feldman, Zhili Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.
Pageof 13